Premium Nahrungsergänzungsmittel | artgerecht

Lipid Panel Analysis – Understanding Blood Fat Levels

A lipid panel analysis is a blood test that measures cholesterol and triglyceride levels to assess the risk of cardiovascular disease.

Regular tips about health Regular tips about health

Things worth knowing about "Lipid Panel Analysis"

A lipid panel analysis is a blood test that measures cholesterol and triglyceride levels to assess the risk of cardiovascular disease.

What Is a Lipid Panel Analysis?

A lipid panel analysis – also known as a lipid profile or lipid screen – is a diagnostic blood test that measures the major fat-related substances in the blood, collectively called lipids. It provides a comprehensive picture of the body´s fat metabolism and is one of the most widely used tools for assessing the risk of cardiovascular diseases such as heart attack and stroke. The test is routinely performed in both general practice and internal medicine as part of preventive healthcare.

What Is Measured?

A standard lipid panel typically includes the following parameters:

Total cholesterol: The overall amount of cholesterol present in the blood.
LDL cholesterol (Low-Density Lipoprotein): Often referred to as the bad cholesterol, it plays a key role in the development of atherosclerosis (hardening of the arteries).
HDL cholesterol (High-Density Lipoprotein): Known as the good cholesterol, it helps remove excess cholesterol from the bloodstream.
Triglycerides: Blood fats that serve as an energy source; elevated levels increase the risk of heart disease.
Non-HDL cholesterol: The total of all cholesterol-containing lipoproteins that contribute to arterial plaque, excluding HDL.
Lipoprotein(a): A genetically determined risk factor for cardiovascular events, measured in extended lipid panels.

When Is a Lipid Panel Ordered?

A lipid panel analysis is recommended in several situations:

As part of routine health screenings, typically recommended from age 35 onwards
When risk factors are present, such as obesity, diabetes mellitus, high blood pressure, or a family history of heart disease
For ongoing monitoring of known dyslipidaemias (disorders of lipid metabolism)
To evaluate the effectiveness of cholesterol-lowering medications, such as statins
Following a heart attack or stroke, for cardiovascular risk stratification

How Is the Test Performed?

For accurate results, patients are usually required to fast for 12 hours before the blood draw, as food intake – especially fat-rich meals – can significantly elevate triglyceride levels. However, current guidelines allow non-fasting measurements for certain parameters such as total cholesterol and LDL cholesterol. Blood is drawn from a vein and sent to a laboratory for analysis.

Interpreting the Results

Lipid panel results are evaluated against internationally recognised reference ranges. Common target values for adults without additional risk factors include:

Total cholesterol: below 200 mg/dL (5.2 mmol/L) is desirable
LDL cholesterol: below 130 mg/dL (3.4 mmol/L) for low-risk individuals; significantly lower targets apply for high-risk patients
HDL cholesterol: above 40 mg/dL (1.0 mmol/L) for men, above 50 mg/dL (1.3 mmol/L) for women
Triglycerides: below 150 mg/dL (1.7 mmol/L)

Results must always be interpreted within the broader clinical context of the individual and are not used as standalone diagnostic criteria.

Clinical Significance

Elevated LDL cholesterol and low HDL cholesterol are major risk factors for atherosclerosis – the build-up of plaques in the arterial walls. If left untreated, this can lead to heart attack, stroke, or peripheral artery disease. Early detection through a lipid panel analysis enables targeted intervention through dietary changes, increased physical activity, or medication.

References

Mach F et al. - 2019 ESC/EAS Guidelines for the management of dyslipidaemias. European Heart Journal. 2020;41(1):111-188.
American Heart Association (AHA) - Cholesterol: Understanding Your Risk. AHA Scientific Statement. 2021.
World Health Organization (WHO) - Cardiovascular diseases: prevention and management of dyslipidaemias. WHO Technical Report. Geneva, 2021.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.